Search for: "Hospira, Inc."
Results 181 - 200
of 287
Sorted by Relevance
|
Sort by Date
5 Mar 2024, 10:23 am
Hospira, Inc., 946 F.3d 1333 (Fed. [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel) –… [read post]
1 May 2017, 10:58 am
Hospira, Inc., 827 F.3d 1363 (Fed. [read post]
16 Mar 2011, 8:18 am
Texas and other states that use lethal injection have been scrambling to find a substitute for sodium thiopental since the only American producer of it, Illinois-based Hospira Inc., announced in January it would stop selling the drug. [read post]
20 Aug 2019, 2:05 am
Hospira, Inc., the Federal Circuit found the claim amendments at issue to be “tangential” to the “equivalent” at issue, and upheld findings of infringement. [read post]
26 Jan 2011, 8:13 am
States across the country have scrambled to find supplies of sodium thiopental after Hospira Inc., of Lake Forest, Ill., the drug's lone U.S. manufacturer, stopped producing it more than a year ago. [read post]
3 Nov 2014, 9:48 am
Hospira, Inc.,[2] Par Sterile Products (formerly JHP Pharmaceuticals), a manufacturer of ADRENALIN, an FDA-approved injectable epinephrine product, brought Lanham Act claims against several defendants, American Regent Inc., Hospira Inc. and International Medical Systems, Ltd. [read post]
18 May 2016, 8:19 am
Hospira that focuses on the role of secondary indicia of non-obviousness. [read post]
17 Mar 2011, 9:34 am
The change was necessary because Hospira Inc. of Illinois announced in January that it would stop making the anesthetic after Italy objected to Hospira manufacturing an execution drug in that country. [read post]
1 Apr 2016, 8:22 am
Hospira, Inc., No. 15-1210 (bright line limits on secondary indicia of nonobviousness) [CubistPetition] Infringement by Joint Enterprise: Limelight Networks, Inc. v. [read post]
1 Apr 2011, 10:21 am
The drug has been in short supply since its primary manufacturer in the United States, Hospira Inc., stopped making the drug earlier this year. [read post]
30 Jun 2010, 2:14 pm
The NAN warning states that emergency syringes of epinephrine in 1mg/10mL (0.1 mg/ml) are currently on backorder from the Hospira Inc., the only manufacturer of the product after the pharmaceutical company Amphastar stopped making its emergency syringes of the drug in 2009. [read post]
9 May 2012, 7:54 am
" Sodium thiopental has been in short supply since 2010, when the only U.S. manufacturer, Hospira Inc., ended production because of death-penalty opposition from overseas customers. [read post]
10 Jun 2011, 5:30 am
Ever since the production of the anesthetic sodium thiopental was discontinued by its U.S. source (Hospira, Inc.), because of concerns over its use in executions, pentobarbital has rapidly become the anesthetic of choice for U.S. executioners. [read post]
16 Aug 2011, 9:06 am
Drug Enforcement Administration said after the purchase the drug could not be used because the state did not have a license to import it.Sodium thiopental -- one of three drugs in Nebraska's lethal-injection protocol -- has been in short supply since last year, when the only U.S. manufacturer, Hospira Inc., said it was ending production because of death-penalty opposition overseas.In July, Soucie asked Douglas County District Judge Thomas Otepka to vacate Moore's death… [read post]
19 Mar 2014, 9:00 am
At the same time, in January 2014 two Celltrion (Hospira) SEBs relying on REMICADE were approved in Canada (another significant development given these are only the 2nd and 3rd approved SEBs in Canada). [read post]
4 Jan 2013, 7:03 am
Hospira, 675 F.3d 1324 (Fed. [read post]
30 Nov 2010, 8:49 am
It is believed this supply was secured overseas, since Hospira Inc., the U.S. maker of the drug, has said its current domestic supply of thiopental expires in 2011. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape… [read post]
7 Dec 2010, 8:55 am
The order was placed overseas after the department's domestic supplier Hospira Inc. [read post]
